Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.39 USD | +0.60% | -4.01% | +13.38% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 414M |
---|---|---|---|---|---|
Net income 2024 * | -37M | Net income 2025 * | -64M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-14.4
x | P/E ratio 2025 * |
-8.55
x | Employees | 38 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.67% |
Latest transcript on Cartesian Therapeutics, Inc.
1 day | +0.19% | ||
1 week | +2.69% | ||
Current month | +5.35% | ||
1 month | +77.21% | ||
3 months | +13.92% | ||
Current year | +12.42% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 23.45 | +0.86% | 4 845 |
24-05-08 | 23.25 | +0.19% | 41,193 |
24-05-07 | 23.2 | -9.85% | 82,896 |
24-05-06 | 25.74 | +0.55% | 67,692 |
24-05-03 | 25.6 | +4.79% | 137,405 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.42% | 414M | |
+2.93% | 108B | |
+8.82% | 105B | |
+1.46% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |
- Stock Market
- Equities
- RNAC Stock